FDA Adverse Event
Injury
Summary report: N
SOFTFORM FACIAL IMPLANT
MDR report key: 205316
·
Received January 8, 1999
Report
- Report Number
- 2027148-1999-00007
- Event Type
- Injury
- Date Received
- January 8, 1999
- Date of Event
- July 16, 1998
- Report Date
- January 8, 1999
- Manufacturer
- TISSUE TECHNOLOGIES, INC.
- Product Code
- FTL
- Removal / Correction Number
- NA
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FL, US
- Reporter Occupation
- PHYSICIAN
Narratives
Description of Event or Problem · 1
PT IMPLANTED IN UPPER AND LOWER VERMILION BORDERS 12/01/1997. ONSET OF SWELLING, PALPABLE, VISIBLE AND IMPLANT SHORTENING 12/02/1997. PT TREATED WITH KENALOG 12/17/1997, REVISED 01/12/1998 TREATED WITH KENALOG 03/11/1998, HYDROCORTISONE 04/13/1998, REVISED 07/16/1998 AND TREATED WITH KENALOG 07/16/1998.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | SOFTFORM FACIAL IMPLANT Implant | SOFTFORM | FTL | TISSUE TECHNOLOGIES, INC. | NA | K03048 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 51 YR | Required Intervention | 1. BACTROBAN (12/01/1997 TO 12/1997),| 2. CEFTIN (11/30/1997 TO 12/06/1997),| 3. VALTREX (11/30/1997 TO 12/06/1997). |